Tag: Cancer: Misc.
Late Cancer Diagnosis Biggest Health Concern for Most, Poll Shows
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D
Risk reduced for 10 of 13 obesity-associated cancers with GLP-1 RA use versus insulin in individuals with type 2 diabetes
Mediterranean Diet Adherence Tied to Lower Mortality for Cancer Survivors
Each 2-point increase in Mediterranean diet score linked to significantly lower all-cause mortality
Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy Outcomes
Similar serious adverse event rate, clinical benefit seen for patients with versus those without a waiver
Vaginal Cancer Incidence Increasing Globally
Risk factors include unsafe sex and HIV infection
Racial Differences Seen in Financial Hardship Among Older Cancer Survivors
Income and area-level disadvantage are the largest contributors to racial differences
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
89 percent of cancer centers report that cancer drugs are in short supply, most often vinblastine, etoposide, and topotecan
FDA Approves Augtyro for NTRK-Positive Advanced Solid Tumors
Approval is for both TKI-naive and TKI-pretreated patients across solid tumor types
Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors
Highest prevalence of all outcomes seen among transgender or gender-nonconforming survivors
Alternative Pembrolizumab Administration Yields Environmental Advantages
Weight-based, extended interval dosing and pharmacy-level stewardship strategies would result in fewer administration events
